Clinical Trials
Our practice participates in clinical trials of medical devices and therapies. Patients may be offered the chance to become study subjects if appropriate. In most cases, participation in a clinical trial gives the patient access to therapeutic options that are not available outside of a clinical study. In most trials, patients who participate receive free evaluations and testing and may receive free study medications or even financial compensation to participate. Participation is strictly voluntary and patients will be informed of known risks and potential benefits of participation in any given study.
Current studies:
EXCEL study - This is a post-marketing study sponsored by Novartis and Genentech to evaluate the safety and effectiveness of the IgE blocker drug Xolair. This study was just completed and is no longer recruiting new patients.
VENT study This is a device study sponsored by Emphasys Medicalof a device intended to help patients with emphysema. It is currently closed for enrollment of new patients
COMPASS-2 study - This is a drug study sponsored by Actelion Pharmaceuticals testing the combination of sildenafil and bosentan for treatment of Pulmonary Arterial Hypertension.
AURA study - This is a drug study sponsored by Altana Pharma testing roflumilast, a new drug for treatment of Chronic Obstructive Pulmonary Disease (COPD). It is currently closed for enrollment of new patients and the drug Daliresp is now FDA approved and on the market.
Athena-1 study - This is a drug study sponsored by Gilead pharmaceuticals to evaluate the safety and effectiveness of the combination of sildenafil and ambrisentan for treatment of Pulmonary Arterial Hypertension. This study is closed for patient recruitment
Aries-3 study - This is a drug study sponsored by Gilead pharmaceuticals to evaluate the safety and effectiveness of ambrisentan for treatment of Pulmonary Arterial Hypertension. This study is completed and is closed for patient recruitment.
ASPIRE study - This is a phase IV (post marketing) study to monitor side effects from Tyvaso - an inhaled prostacyclin for treatment of Pulmonary Arterial Hypertension.